切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2024, Vol. 18 ›› Issue (03) : 245 -252. doi: 10.3877/cma.j.issn.1674-0785.2024.03.003

临床研究

京西地区无心血管病史2型糖尿病中老年人群患心血管疾病的危险因素分析
孙秀芹1, 高美娟2, 张琼阁1, 吕凯敏1, 王宏宇1,()   
  1. 1. 100144 北京,北京大学首钢医院内分泌科
    2. 100040 北京,北京石景山医院内分泌科
  • 收稿日期:2024-01-08 出版日期:2024-03-15
  • 通信作者: 王宏宇

Cardiovascular risk factors in middle-aged and elderly people with type 2 diabetes without cardiovascular history in western Beijing

Xiuqin Sun1, Meijuan Gao2, Qiongge Zhang1, Kaimin Lv1, Hongyu Wang1,()   

  1. 1. Department of Endocrinology, Peking University Shougang Hospital, Beijing 100144, China
    2. Department of Endocrinology, Beijing Shijingshan Hospital, Beijing 100040, China
  • Received:2024-01-08 Published:2024-03-15
  • Corresponding author: Hongyu Wang
引用本文:

孙秀芹, 高美娟, 张琼阁, 吕凯敏, 王宏宇. 京西地区无心血管病史2型糖尿病中老年人群患心血管疾病的危险因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(03): 245-252.

Xiuqin Sun, Meijuan Gao, Qiongge Zhang, Kaimin Lv, Hongyu Wang. Cardiovascular risk factors in middle-aged and elderly people with type 2 diabetes without cardiovascular history in western Beijing[J/OL]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(03): 245-252.

目的

探讨京西地区无心血管疾病的中老年2型糖尿病(T2DM)人群的临床特点以及心血管疾病(CVD)危险因素分析。

方法

本研究为横断面研究。选取北京市石景山区某社区常住居民为研究对象,排除心血管疾病患者。调查内容包括问卷调查、体格检查和实验室检查;问卷调查内容包括人口学特征、行为、个人疾病史;体格检查包括身高、体重指数(BMI)和血压;实验室检查包括空腹血糖、糖化血红蛋白(HbA1c)、总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)和高密度脂蛋白胆固醇(HDL-C)、外周动脉张力测定、动脉硬度、心踝血管指数(CAVI)、踝-肱指数(ABI)、颈动脉内膜中层厚度(CIMT)等。组间比较采用t检验,计数资料比较采用χ2检验,采用多因素Logistic 回归分析分析T2DM患者的CVD影响因素。

结果

共有效调查1575名受试者,其中糖尿病组308人(19.5%),无糖尿病组1267人(84.5%)。糖尿病组人群的年龄、BMI、空腹血糖和HbA1c均高于无糖尿病组者,糖尿病组受教育程度、TC、HDL-C、LDL-C水平低于无糖尿病组者。糖尿病组吸烟、饮酒、早发心脑血管疾病家族史、高脂血症、高血压、颈部血管硬化、斑块或狭窄占比均高于无糖尿病组者。多元逻辑回归分析显示,糖尿病与心血管疾病家族史、“TC”、“HDL-C”、“LDL-C”、“颈动脉超声正常”呈负相关,与“心率”、肱踝动脉脉搏波速度(BA-PWV)和“心-踝血管指数(CAVI)”呈正相关。即糖尿病组肱踝动脉 较非糖尿病组偏硬,颈动脉内膜增厚、斑块多发在糖尿病组更多。

结论

糖尿病患者往往伴有多个心血管疾病危险因素。年龄、体重指数、吸烟、饮酒、早发CVD家族史、高脂血症、高血压、颈动脉硬化和糖尿病呈正相关,而患者受教育程度与糖尿病呈负相关。

Objective

To investigate the clinical characteristics and risk factors of cardiovascular diseases (CVD) in middle-aged and elderly people with type 2 diabetes (T2DM) without a history of cardiovascular disease in western Beijing.

Methods

This study is a cross-sectional study. Permanent residents in a community in Shijingshan District of Beijing were selected as the research subjects, and patients with CVD were excluded. The survey content included questionnaire survey, physical examination, and laboratory tests. The questionnaire survey included demographic characteristics, behavior, and personal medical history. Physical examination included height, body mass index (BMI), and blood pressure. Laboratory tests included fasting blood glucose, glycated hemoglobin (HbA1c), total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), peripheral arterial tone measurement, arterial hardness, cardiovascular ankle index (CAVI), ankle brachial index (ABI), carotid intima-media thickness (CIMT), etc. The t-test was used for intergroup comparisons, and count data comparison was performed using the χ2 test. Multiple logistic regression analysis was performed to identify the influencing factors of CVD in T2DM patients.

Results

A total of 1575 valid subjects were investigated, including 308 (19.5%) in the diabetes group and 1267 (84.5%) in the non diabetes group. Age, BMI, fasting blood glucose, and HbA1c in the diabetes group were higher than those of the diabetes-free group. Educational level, TC, HDL-C, and LDL-C in the diabetes group were lower than those of the diabetes-free group. The percentages of subjects with smoking, drinking, family history of early cardiovascular and cerebrovascular diseases, hyperlipidemia, hypertension, cervical vascular sclerosis, plaque, or stenosis in the diabetes group were higher than those of the non-diabetes group. Multivariate logistic regression analysis showed that diabetes was negatively correlated with family history of cardiovascular disease, TC, HDL-C, LDL-C, and normal carotid ultrasound manifestations, and positively correlated with heart rate, brachial ankle artery pulse wave velocity (BA-PWV), and cardiac ankle vascular index (CAVI). That is, the brachial ankle artery in the diabetes group was harder than that in the non-diabetes group, and carotid artery intima thickening and plaque were more common in the diabetes group.

Conclusion

Patients with diabetes are often associated with multiple cardiovascular disease risk factors. Age, BMI, smoking, drinking, family history of early CVD, hyperlipidemia, hypertension, carotid atherosclerosis, and diabetes are positively correlated with diabetes, while patients' education level is negatively correlated with diabetes.

表1 2组人群的基本特征分析
表2 糖尿病者心血管疾病危险因素分析
临床特征 糖尿病组(n=308) 无糖尿病组(n=1267) χ2/t P
性别,n(%) 2.939 0.086
117(38) 416(32.8)
191(62) 851(67.2)
受教育程度,n(%) 13.713 0.018
文盲 5(1.6) 3(0.2)a
小学 7(2.3) 29(2.3)
初中 95(30.8) 325(25.7)
高中或中专 129(41.9) 596(47)
本科或大专 71(23.1) 307(24.2)
研究生及以上 1(0.3) 7(0.6)
吸烟状态,n(%) 8.702 0.013
从不吸烟 205(66.6) 946(74.7)a
已戒烟 38(12.3) 108(8.5)a
目前仍吸烟 65(21.1) 213(16.8)
饮酒状态,n(%) 9.131 0.010
从不饮酒 193(62.7) 900(71)a
过去饮现在不饮 14(4.5) 34(2.7)
现饮酒 101(32.8) 333(26.3)a
亲属是否有心脑血管疾病病史,n(%) 13.353 0.001
62(20.1) 379(29.9)a
有,非早发 61(19.8) 255(20.1)
有,早发 185(60.1) 633(50.0)a
高血压,n(%) 64.043 <0.001
183(59.4) 438(34.6)
125(40.6) 829(65.4)
高脂血症,n(%) 48.661 <0.001
182(59.1) 472(37.3)
126(40.9) 795(62.7)
rBA-PWV 1572.22±246.38 1456.63±226.26 7.900 <0.001
lBA-PWV 1646.75±277.70 1524.19±248.97 7.084 <0.001
R-ABI 1.05±0.11 1.05±0.11 0.445 0.657
L-ABI 1.07±0.13 1.14±0.26 -0.470 0.638
右侧ba-pwv与同年龄性别相比,n(%) 26.184 <0.001
正常 141(45.8) 638(50.4)
偏硬 127(41.2) 350(27.6)a
弹性大 40(13) 279(22)a
左侧ba-pwv与同年龄性别相比,n(%) 27.902 <0.001
正常 110(35.7) 610(48.1)a
偏硬 167(54.2) 478(37.7)a
弹性大 31(10.1) 179(14.1)
R-CAVI 8.95±1.10 8.43±1.06 7.729 <0.001
L-CAVI 8.88±1.09 8.49±2.52 2.684 0.007
左侧颈动脉超声,n(%) 36.572 <0.001
正常 126(40.9) 722(57)a
内中膜增厚 15(4.9) 68(5.4)
狭窄 10(3.2) 17(1.3)a
闭塞 0(0) 1(0.1)
单发斑块 120(39) 385(30.4)a
多发 37(12) 74(5.8)a
右侧颈动脉超声,n(%) 32.832 <0.001
正常 147(47.7) 767(60.5)a
内中膜增厚 9(2.9) 67(5.3)
狭窄 11(3.6) 20(1.6)a
闭塞 0(0) 1(0.1)
单发斑块 111(36) 355(28)a
多发斑块 30(9.7) 57(4.5)a
RHI 1.86±0.60 1.88±0.58 -0.625 0.532
表3 糖尿病者心血管危险因素多因素分析
指标 β值 SE值 Wald OR值 95%CI值 P
吸烟状态
从不吸烟 -0.271 0.178 2.324 0.762 0.538,1.081 0.127
已戒烟 0.234 0.361 0.421 1.264 0.623,2.563 0.516
亲属是否有心脑血管疾病病史
-0.414 0.172 5.815 0.661 0.472,0.925 0.016
有,非早发 -0.144 0.175 0.676 0.866 0.615,1.220 0.411
收缩压 0.002 0.004 0.156 1.002 0.993,1.001 0.693
肌酸激酶同工酶 0.018 0.006 8.416 1.018 1.006,1.030 0.004
总胆固醇 -0.294 0.067 19.075 0.745 0.653,0.851 <0.001
高密度脂蛋白胆固醇 -0.744 0.240 9.654 0.475 0.297,0.760 0.002
低密度脂蛋白胆固醇 -0.323 0.091 12.498 0.724 0.605,0.866 <0.001
心率 0.021 0.007 10.045 1.021 1.008,1.034 0.002
rBA-PWV 0.001 <0.001 21.488 1.001 1.001,1.002 <0.001
lBA-PWV 0.001 <0.001 18.888 1.001 1.001,1.002 <0.001
右侧ba-pwv与同年龄性别相比
正常 0.365 0.205 3.175 1.440 0.964,2.151 0.075
偏硬 0.763 0.214 12.678 2.144 1.409,3.262 <0.001
左侧ba-pwv与同年龄性别相比
正常 -0.123 0.234 0.276 0.884 0.559,1.399 0.599
偏硬 0.465 0.231 4.051 1.592 1.012,2.505 0.044
R-CAVI 0.355 0.074 22.959 1.426 1.233,1.649 <0.001
L-CAVI 0.031 0.024 1.625 1.031 0.984,1.081 0.202
左侧颈动脉超声
正常 -0.636 0.247 6.623 0.530 0.326,0.859 0.010
内中膜增厚 -0.461 0.373 1.529 0.630 0.303,1.310 0.216
狭窄 0.241 0.484 0.248 1.272 0.493,3.283 0.619
闭塞 -16.925 <0.001 - - - -
单发 -0.296 0.243 1.485 0.743 0.461,1.198 0.223
右侧颈动脉超声
正常 -0.610 0.264 5.339 0.543 0.324,0.912 0.021
内中膜增厚 -1.128 0.448 6.343 0.324 0.135,0.779 0.012
狭窄 -0.050 0.483 0.011 0.951 0.369,2.449 0.917
闭塞 -16.621 <0.001 - - - -
单发 -0.293 0.267 1.200 0.746 0.442,1.260 0.273
1
Magliano DJ, Boyko EJ; IDF Diabetes Atlas 10th edition scientific committee. IDF DIABETES ATLAS [Internet] [J]. 10th ed. Brussels: International Diabetes Federation, 2021.
2
Li Y, Teng D, Shi X, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study [J]. BMJ, 2020,369: m997.
3
Sarwar N, Gao P, Seshasai SR, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies [J]. Lancet, 2010,375(9733): 2215-2222.
4
Cosentino F, Grant PJ, Aboyans V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD [J]. Eur Heart J, 2020,41(2): 255-323.
5
American Diabetes Association Professional Practice Committee. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022 [J]. Diabetes Care, 2022,45(Suppl 1): S17-S38.
6
International classification of diseases. World Health Organization [J].2022.
7
Mikton CR, Butchart A, Dahlberg LL, et al. Global status report on violence prevention 2014 [J]. Am J Prev Med, 2016,50(5): 652-659.
8
本刊记者.中共中央国务院印发《“健康中国2030”规划纲要》大健康产业大有可为健康中国势在必行 [J].中国品牌与防伪, 2023,(S1): 4-6.
9
中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2021概要 [J]. 中国循环杂志, 2022,37(6): 553-578.
10
Visseren FLJ, Mach F, Smulders YM, et al. [2021 ESC Guidelines on cardiovascular disease prevention in clinical practice] [J]. G Ital Cardiol (Rome), 2022,23(6 Suppl 1): e3-e115.
11
Paul SK, Klein K, Thorsted BL, et al. Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes [J]. Cardiovasc Diabetol, 2015,14: 100.
12
Hu FB, Stampfer MJ, Haffner SM, et al. Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes [J]. Diabetes Care, 2002,25(7): 1129-1134.
13
苏文, 陈晖, 李虹伟. 高血糖及降糖治疗对冠心病的影响 [J/OL]. 中华临床医师杂志(电子版), 2012,6(22): 7344-7346.
14
Unnikrishnan AG, Sahay RK, Phadke U, et al. Cardiovascular risk in newly diagnosed type 2 diabetes patients in India [J]. PLoS One, 2022,17(3): e0263619.
15
张颖, 胡舜英, 周浩, 等. 胰高血糖素样肽-1的心血管保护作用 [J/OL]. 中华临床医师杂志(电子版), 2017,11(1): 109-113.
16
Kaul U, Arambam P, Rao S, et al. Usefulness of ambulatory blood pressure measurement for hypertension management in India: the India ABPM study [J]. Journal of human hypertension, 2020,34(6): 457-467.
17
Kaul U, Bhagwat A, Omboni S, et al. Blood pressure and heart rate related to sex in untreated subjects: the India ABPM study [J]. J Clin Hypertens (Greenwich), 2020,22(7): 1154-1162.
18
Wormser D, Kaptoge S, Di Angelantonio E, et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies [J]. Lancet, 2011,377(9771): 1085-1095.
19
Lean MEJ, Leslie WS, Barnes AC, et al. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial [J]. Lancet Diabetes Endocrinol, 2019,7(5): 344-355.
20
Sattar N, Welsh P, Leslie WS, et al. Dietary weight-management for type 2 diabetes remissions in South Asians: the South Asian diabetes remission randomised trial for proof-of-concept and feasibility (STANDby) [J]. Lancet Reg Health Southeast Asia, 2023,9: 100111.
21
Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD). Evidence-based European recommendations for the dietary management of diabetes [J]. Diabetologia, 2023,66(6): 965-985.
22
Sarathi V, Kolly A, Chaithanya HB, et al. High rates of diabetes reversal in newly diagnosed Asian Indian young adults with type 2 diabetes mellitus with intensive lifestyle therapy [J]. J Nat Sci Biol Med, 2017,8(1): 60-63.
23
Hoong JM, Koh HA, Wong K, et al. Effects of a community-based chronic disease self-management programme on chronic disease patients in Singapore [J]. Chronic Illn, 2023,19(2): 434-443.
24
Van de Velde D, De Zutter F, Satink T, et al. Delineating the concept of self-management in chronic conditions: a concept analysis [J]. BMJ Open, 2019,9(7): e027775.
25
Asmat K, Dhamani K, Froelicher ES, et al. A patient-centered self-management intervention to improve glycemic control, self-efficacy and self-care behaviors in adults with type 2 diabetes mellitus: A spirit compliant study protocol for randomized controlled trial [J]. Diabetes Metab Syndr Obes, 2023,16: 225-236.
[1] 郝玥萦, 毛盈譞, 张羽, 汪佳旭, 韩林霖, 匡雯雯, 孟瑶, 杨秀华. 超声引导衰减参数成像评估肝脂肪变性及其对心血管疾病风险的预测价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 770-777.
[2] 曹雯佳, 刘学兵, 罗安果, 钟释敏, 邓岚, 王玉琳, 李赵欢. 超声矢量血流成像对2型糖尿病患者颈动脉壁剪切应力的研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(07): 709-717.
[3] 庄燕, 戴林峰, 张海东, 陈秋华, 聂清芳. 脓毒症患者早期生存影响因素及Cox 风险预测模型构建[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(05): 372-378.
[4] 黄鸿初, 黄美容, 温丽红. 血液系统恶性肿瘤患者化疗后粒细胞缺乏感染的危险因素和风险预测模型[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(05): 285-292.
[5] 贺斌, 马晋峰. 胃癌脾门淋巴结转移危险因素[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 694-699.
[6] 孟令凯, 李大勇, 王宁, 王桂明, 张炳南, 李若彤, 潘立峰. 袖状胃切除术对肥胖伴2型糖尿病大鼠的作用及机制研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 638-642.
[7] 李猛, 姜腊, 董磊, 吴情, 贾犇黎. 腹腔镜胃袖状切除术治疗肥胖合并2型糖尿病及脂肪胰的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 554-557.
[8] 林凯, 潘勇, 赵高平, 杨春. 造口还纳术后切口疝的危险因素分析与预防策略[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 634-638.
[9] 杨闯, 马雪. 腹壁疝术后感染的危险因素分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 693-696.
[10] 周艳, 李盈, 周小兵, 程发辉, 何恒正. 不同类型补片联合Nissen 胃底折叠术修补食管裂孔疝的疗效及复发潜在危险因素[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 528-533.
[11] 宋新雅, 苏小慧, 卞士柱, 丁小涵. 吸入性药物治疗肺动脉高压的研究进展[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 831-835.
[12] 冯熔熔, 苏晓乐, 王利华. 慢性肾脏病患者并发心血管疾病相关生物标志物研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(05): 273-278.
[13] 颜世锐, 熊辉. 感染性心内膜炎合并急性肾损伤患者的危险因素探索及死亡风险预测[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 618-624.
[14] 王璇, 娜扎开提·尼加提, 雒洋洋, 蒋升. 皮肤晚期糖基化终末产物浓度与2型糖尿病微血管并发症的相关性[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 447-454.
[15] 王星, 陈园, 热孜万古丽·乌斯曼, 郭艳英. T2DM、Obesity、NASH、PCOS共同致病因素相关的分子机制[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 481-490.
阅读次数
全文


摘要